Cost Effectiveness
E-consult program for immune-related toxicities reduces costs, increases patient access
An electronic consult program for patients who developed endocrine immune-related adverse events has considerably reduced health care utilization.
Report: Sotatercept improves clinical outcomes in PAH, but unlikely to be cost-effective
When added to background therapy for pulmonary arterial hypertension, sotatercept improves 6-minute walk distance and WHO functional class vs. placebo, according to an evidence report by the Institute for Clinical and Economic Review.
Tobacco cessation program in primary care cost-effective, increased cessation rates
A tobacco cessation program was cost-effective and increased smoking cessation rates by 7.4%, a study in the American Journal of Preventive Medicine showed.
Cost-effectiveness of sacubitril/valsartan increases at lower ranges of LVEF
Researchers reported that sacubitril/valsartan was more cost-effective for patients with HF and reduced left ventricular ejection fraction vs. those with HF with mildly reduced EF, for whom it was of intermediate value.
Focused ultrasound cost-effective, improves athletes’ risk detection for cardiac death
Pre-participation screening for risk factors for sudden cardiac death with focused cardiac ultrasound was shown to improve diagnosis in athletes while remaining cost-effective, researchers reported.
Protocol AC shows cost-effectiveness of using bevacizumab first in center-involved DME
SEATTLE — In eyes with center-involved diabetic macular edema, using bevacizumab first and switching to aflibercept if needed is more cost-effective over 2 years as compared with aflibercept monotherapy, according to DRCR Protocol AC.
Quadruple therapy borderline cost-effective for HFrEF; drug prices continue to rise
Researchers reported quadruple therapy with SGLT2 and angiotensin receptor-neprilysin inhibition was narrowly cost-effective compared with standard care plus SGLT2 inhibition alone for patients with HF and reduced ejection fraction.
Deep brain stimulation effective, cost-efficient option for advanced Parkinson’s
CHICAGO — Deep brain stimulation was a cost-effective and clinically efficacious option for advanced Parkinson’s disease compared with medical therapy for patients in the Vietnamese health care system, according to research.
General practitioner-led HeFH screening, care may be cost-effective vs. standard care
An Australian general practitioner-led screening and care program for heterozygous familial hypercholesterolemia was projected to be cost-effective with significant return on investment vs. standard care, researchers reported.
Early rhythm control strategy for AF may be cost-effective
An early rhythm control strategy for treatment of atrial fibrillation was cost-effective in a German population, according to new data from the EAST-AFNET 4 trial.